Paul H. Fischer
Keine laufenden Positionen mehr
Profil
Paul H.
Fischer served as the President, Chief Executive Officer & Director of GenVec, Inc. from 1996 to 2012.
Prior to that, he worked as a Manager-Cancer Research at Pfizer Inc. and as an Executive Vice President-Research & Development at Agenus, Inc. Fischer holds a doctorate from The University of California, San Francisco and an undergraduate degree from the University of Denver.
Ehemalige bekannte Positionen von Paul H. Fischer
| Unternehmen | Position | Ende |
|---|---|---|
| GENVEC INC | Vorstandsvorsitzender | 22.05.2012 |
| PFIZER, INC. | Corporate Officer/Principal | - |
| AGENUS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Paul H. Fischer
| University of Denver | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AGENUS INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |